Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Poor antibody validation wastes millions of biological samples
A widespread failure to validate research antibodies before use is believed to have led to the...
Antibody treatment reprograms immune system after heart attack
A new drug being trialled in heart attack patients could reprogram the immune system to prevent...
Nanoparticles supercharge vinegar's wound-healing power
Adding microscopic particles to vinegar can make them more effective against dangerous bacterial...
